Product image of Morphine (Sulfate) Lavoisier (Morphine Sulfate) supplied by GNH India

Morphine (Sulfate) Lavoisier

Active Ingredient:
Morphine Sulfate
Origin:
EU

Morphine (Sulfate) Lavoisier (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphine (Sulfate) Lavoisier, is an opioid analgesic presented as a sterile solution for epidural, intracerebroventricular and intrathecal use. It provides potent pain relief for severe acute pain and chronic cancer pain in adult patients.

GNH India supplies Morphine (Sulfate) Lavoisier as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Laboratoires Chaix Et Du Marais

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Morphine sulfate is an opioid analgesic indicated for conditions involving severe nociceptive pain.

  • Severe acute pain: delivers rapid, strong analgesia to control breakthrough pain.
  • Chronic cancer pain: manages persistent pain associated with malignant disease.
  • Palliative care pain: provides sustained relief for patients with advanced illness.

How It Works

  • Morphine sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to decreased neuronal excitability and suppression of pain signal transmission, resulting in analgesia and sedation.

Side Effects

Morphine sulfate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Constipation: reduced bowel motility.
  • Drowsiness: increased sleepiness.
  • Dizziness: sensation of light‑headedness.
  • Itching: pruritus, often localized.
  • Urinary retention: difficulty emptying bladder.

Serious or Rare Side Effects

  • Respiratory depression: slowed breathing, potentially life‑threatening.
  • Hypotension: marked drop in blood pressure.
  • Severe allergic reaction: rash, swelling, anaphylaxis.
  • Adrenal insufficiency: impaired stress response.
  • Seizures: rare neurologic events.
  • Dependence or addiction: risk of misuse with prolonged use.

Precautions & Warnings

Morphine sulfate requires careful clinical monitoring to minimize risks.

  • Assess respiratory function: monitor for depression, especially after dose changes.
  • Evaluate renal and hepatic function: adjust dosing in impairment.
  • Avoid concurrent CNS depressants: increased sedation and respiratory risk.
  • Use caution in elderly patients: heightened sensitivity to effects.
  • Pregnancy and lactation: weigh benefits against potential fetal or neonatal risks.
  • Store below 25°C: keep in original container, protect from moisture and light.

Avoid Interactions

Morphine sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid)

  • Benzodiazepines: additive respiratory depression.
  • MAO inhibitors: risk of severe hypertension or serotonin syndrome.
  • CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): reduced analgesic effect.
  • Anticholinergic agents: may worsen constipation.

Frequently Asked Questions

Morphine (Sulfate) Lavoisier is an opioid analgesic used to treat severe acute pain, chronic cancer‑related pain, and other intense pain conditions where strong, rapid relief is required. It is administered by healthcare professionals via epidural, intracerebroventricular or intrathecal routes.

Morphine sulfate binds to mu‑opioid receptors in the brain and spinal cord, activating them to inhibit the release of neurotransmitters that transmit pain signals. This reduces neuronal excitability, leading to decreased perception of pain and a calming, sedative effect.

The appropriate dose of morphine sulfate is determined individually by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and other clinical factors. No standard dose is provided here.

Data on morphine use in pregnancy and lactation are limited. It may cross the placenta and enter breast milk, potentially affecting the fetus or infant. Clinicians must weigh the therapeutic benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Morphine and fentanyl are both potent opioids, but morphine has a longer onset and duration of action, making it suitable for continuous infusion or epidural use. Fentanyl is more lipophilic, offering rapid onset and shorter duration, often preferred for breakthrough pain or transdermal patches.

Morphine sulfate should be stored below 25 °C in its original packaging, protected from moisture and light. Keep the product in a secure area with restricted access, and follow local regulations for handling controlled substances.

Morphine sulfate is administered by qualified healthcare professionals via epidural, intracerebroventricular, or intrathecal injection. The route is selected based on the clinical situation, and dosing is adjusted according to patient response and safety monitoring.

The most serious risks include respiratory depression, severe hypotension, profound sedation, potential for dependence or addiction, and rare allergic reactions. Continuous monitoring of respiratory and cardiovascular status is essential, especially after dose adjustments.

Morphine sulfate is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, those with severe respiratory insufficiency, uncontrolled asthma, or paralytic ileus. Caution is also advised for individuals with significant head injury or increased intracranial pressure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Morphine Sulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT